Our Cochrane systematic review on glucocorticosteroids versus placebo or no intervention for people with alcoholic hepatitis found no evidence of a difference on clinically important outcomes at either of the three timepoints of follow-up.(4) Our review (last search 18.01.2019) was based on a pre-published, peer-reviewed protocol. In a subgroup meta-analysis of 14 trials with 1679 participants with severe alcoholic hepatitis, we found no evidence of effect of glucocorticosteroids on mortality.(4).
Letter to the Editor: Glucocorticosteroids for alcoholic for alcoholic hepatitis / D. Varganova, C.S. Pavlov, D. Nikolova, C. Gluud, G. Casazza. - In: HEPATOLOGY. - ISSN 0270-9139. - 71:4(2020 Apr), pp. 1524-1524. [10.1002/hep.31010]
Letter to the Editor: Glucocorticosteroids for alcoholic for alcoholic hepatitis
G. CasazzaUltimo
2020
Abstract
Our Cochrane systematic review on glucocorticosteroids versus placebo or no intervention for people with alcoholic hepatitis found no evidence of a difference on clinically important outcomes at either of the three timepoints of follow-up.(4) Our review (last search 18.01.2019) was based on a pre-published, peer-reviewed protocol. In a subgroup meta-analysis of 14 trials with 1679 participants with severe alcoholic hepatitis, we found no evidence of effect of glucocorticosteroids on mortality.(4).
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020 Hepatology Letter to the Editor Glucocorticosteroids for Alcohol-Associated.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
74.41 kB
Formato
Adobe PDF
|
74.41 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
